Familial Mediterranean Fever (FMF)
Conditions
Interventions
None listed
Sponsors
Yokohama City University Graduate School of Medicine
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: (1) The published study including case-control study, cohort study, and randomized clinical trial. (2) The experimental group of the study was FMF with healthy control. (3) The patients were clinically diagnosed with FMF. (5) The study illustrated the pregnancy outcomes of FMF.
Exclusion criteria
Exclusion criteria: (1) Systematic review or meta-analysis articles. (2) Case reports or case series reporting less than 5 cases. (3) The republished research literature is excluded unless the research includes new findings related to pregnancy outcomes. (4) Studies published in languages other than English.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome: The primary endpoints are miscarriage, premature delivery and fetal growth restriction. The odds ratio (OR) will be calculated. Meta-analysis will be performed to compare the incidence of co-primary outcomes between FMF patients and healthy controls. | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary outcomes are hypertensive disorders, caesarean delivery and fetal anomaly. | — |
Countries
Japan
Contacts
Public ContactKaoru Minegishi
Yokohama City University Graduate School of Medicine Department of Stem Cell and Immune Regulation
Outcome results
None listed